Episode 15: Purpose and The Power of Life’s Detours - Ravi Patel, SVP Global Patient Safety at United Therapeutics

In this thoughtful, inspiring conversation, Ravi Patel, Senior Vice President of Global Patient Safety at United Therapeutics, sits down with Patty to explore how drug safety is evolving in an era of exploding data and rapid innovation. Having immigrated from India at 12, able to understand English but not yet speak it with confidence, Ravi shares how early challenges, and one unexpected career detour, shaped an empathetic leadership style and a lasting passion for clinical development. 

You’ll hear Ravi and Patty dig into why pharmacovigilance has reached a pivotal moment, how the industry can embrace AI responsibly without sacrificing trust, and what it takes to break down the silos that slow drug development. They also explore the value of executive sponsorship for complex, cross-functional initiatives, and the patient-driven mission behind United Therapeutics’ bold work in rare disease and organ manufacturing. This episode explores how drug safety can become a strategic force for innovation, and why patients must remain at the center of it all. 

What you’ll hear about 

• Why is pharmacovigilance facing such a pivotal moment in drug development today? 

• How can safety teams embrace AI without compromising trust or compliance? 

• Can industry collaboration close talent gaps and uneven global readiness? 

• How do you break down silos across the drug development lifecycle? 

• Why does executive sponsorship matter so much for complex cross-functional initiatives? 

• How can a career setback open the door to unexpected success? 

This episode is intended for drug safety and pharmacovigilance leaders, offering a clear perspective on evolving safety from a compliance function into a strategic partner in drug development. 

Timestamps 

00:05 – From Ahmedabad to the land of opportunity 

02:10 – How early struggles shaped an empathetic leader 

03:50 – Finding a path into clinical research 

06:05 – The detour that changed everything 

12:10 – Pharmacovigilance at a crossroads 

16:40 – Moving past hesitation on AI 

18:40 – Collaboration as the path forward 

20:10 – Breaking down silos across drug development 

25:10 – Closing the gaps between handoffs 

28:00 – Bringing commercial voices in early 

29:35 – Why executive buy-in matters 

31:55 – Inside United Therapeutics’ patient-driven mission 

34:40 – Keeping patients at the center of every decision 

Guest Biography 

Ravi Patel is Senior Vice President of Global Patient Safety at United Therapeutics, where he oversees safety for therapies in rare and life-threatening diseases as well as the company’s pioneering work in organ manufacturing. A pharmacist by training with more than two decades of experience at organizations including Bayer and Alexion, he is dedicated to modernizing pharmacovigilance and responsibly advancing the use of AI in patient safety. Driven by a deep sense of responsibility to patients and their families, Ravi works to make drug safety a proactive, strategic partner in bringing new therapies to those who need them most.